Wine Cork Market Innovations, Technology Growth and Research 2028

Consumers prefer to buy wines with cork stoppers. Cork demand has increased due to a larger proportion of wine being sealed with cork rather than being sold in bulk. The wine cork allows optimum control of oxygen transfer through the closure. The outer flexible skin of wine cork provides a traditional appearance.

The elastic property of the cork is influenced by its moisture content. The cork remains fairly elastic for insertion into the bottle within a moisture content. The cork stopper has exclusive distinctive qualities, which interact beneficially with wine. It contributes to developing its character, gives it authenticity and brings it value.

The cork stopper has unique capacities such as impermeability and resistance, which allows managing micro-oxygenation and flawlessly ensures a successful maturation and aging of the wine, while preserving its essence, flexibility etc.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6682

Global wine cork market: Key Developments

In October 2016, Helix packaging company, based in Carlton, Australia developed innovative cork system known as twist-to-open. The new twist-to-open system combines an ergonomically-designed stopper which is made from glass bottle and cork. This creates a high performing and sophisticated packaging solution for wine. Helix Packaging Company has combined all the benefits of cork and glass – quality, sustainability and premium image – with user-friendly, twist open, re-sealable convenience.

Global wine cork market overview

Worldwide wine cork production is estimated to be slightly less than 13 billion in 2017. The estimate includes agglomerated cork stoppers and champagne corks. Worldwide production of cork is estimated to be 3,075,000 tons in 2017.

Global wine cork market: Key players

Some of the key players in the global wine cork market are

  • Jelinek Cork Group,
  • Wine Enthusiast Companies,
  • Widgetco, Inc.,
  • Amorim Cork Composites S.A.,
  • Bangor Cork Inc.,
  • Keval Import Export private limited,
  • Waterloo Container Company,
  • M.A. Silva USA, LLC,
  • Helix Packaging,
  • Precision Elite limited company,
  • Elkem Silicones limited,
  • Allstates Rubber Inc. & Tool Corp.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Ask an Analyst @ https://www.futuremarketinsights.com/askus/rep-gb-6682

Global wine cork market: Segmentation

On the basis of product type, the global wine cork market has been segmented as

  • Natural Wine Corks
  • Ice Wine Natural Corks
  • Pore Filled Natural Wine Corks
  • Double Disc Corks or Twin Top Cork
  • Agglomerate Wine Corks
  • Synthetic Wine Corks
  • Regular Cork
  • Sparkling Wine Corks
  • Wine-Lok / Vinolok
  • Zork
  • Others

Natural cork is mostly used the global wine cork market. Its main objective is to preserve wine for long-term storage. Natural corks, the most popular and well-known, have been used for centuries due to the elasticity of their cellular structure. Natural cork is malleable to a certain extent, with the ability to contract and expand. It is almost airtight because some air is able to pass through natural cork, because microscopically there are holes inside the cork structure. This can be beneficial or harmful, depending on the type of wine that is stored.

Request Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-6682

Related Links –

https://issuu.com/nk99/docs/signage_market_

https://www.slideshare.net/niranjankarde/signage-market-2022-key-players-swot-analysis-key-indicators-and-forecast-to-2031

https://www.pearltrees.com/niranjankarde/item479163590

https://www.evernote.com/client/web?login=true#?an=true&n=6c625675-cfc9-8958-340d-9d48996a07ef&

https://medium.com/@nk99fmi/signage-market-2022-outlook-current-and-future-industry-landscape-analysis-2031-1a9c51852e3e

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse Latest Market reports: https://www.futuremarketinsights.com/reports

Gamma Knife Market Analysis, Future Growth, Business Prospects, Size, Share, Development, Forecast to 2031

This Future Market Insights report examines the ‘Global Gamma Knife’ market for the period 2012-2025. The primary objective of the report is to offer updates on the advancement of Gamma Knife, examining the marketing efforts and business strategies undertaken by the manufacturing companies which is significantly transforming the Stereotactic Radiosurgery market. This study analyses, estimates and forecasts the global Gamma Knife market from the demand as well as supply perspective, in terms of revenue (US$ Mn) during the forecast period 2021 to 2031. The report also highlights the impact of various drivers and restraints in various regions along with their impact during the forecast period.

The report starts with an overview of Gamma Knifein treatment in various indications such as Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others. For example, Cobalt-60 radioactive isotope is increasingly being used for the treatment of brain tumours and cancers in order to increase life expectancy. Moreover, market expansion and innovation in techniques as well as development of novel applications in Stereotactic Radiosurgery are further driving Gamma Knife market growth. Due to these reasons, Gamma Knife market is expected to have a significant demand in the near future.

Request a report sample to gain comprehensive insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-589

There are five major types of Gamma Knife indications which have been covered in this report: Brain Metastasis, Cancer, Arteriovenous Malformation (AVM), Trigeminal Neuralgia and Others. Brain Metastasis treatment contribute around 68.5% share of the global Gamma Knife value in 2014, Brain Metastasis is anticipated to witness a CAGR of 9.2% during the forecast period.

Considering the type of body part treated with Gamma Knife, the global Gamma Knife market is segmented into: Head, Neck and Other body parts. Among the aforementioned segments, Head treatment with Gamma Knife is expected to dominate the global market with over 88.1% market value share throughout the forecast period. The global head treatment with Gamma Knife accounted for US$ 287.3 Mn in 2021, and is anticipated to reach a value of US$ 507.0 Mn by 2031, growing at a CAGR of 5.90% during the forecast period. Moreover, the scope of Gamma Knife treatment in other indications is expected to expand in the future too, due to market expansion and innovation in techniques. This section analysis each indications in terms of market revenue.

On the bases of region, North America dominated the global Gamma Knife market in 2014, in terms of revenue, accounting for more than 29.2% of the revenue share in 2014. However, Europe and Asia Pacific are foreseen to witness relatively high CAGRs of 7.7% and 10.5% respectively. The report provides market revenue for each geographical region.

The global Gamma Knife market in terms of indications, anatomy and region are analysed in terms of Basis Point Share to understand individual segments relative contributions to market growth. This detailed level of information is important for the identification of various key trends of the global Gamma knife market.

For any Queries Related with the Report, Ask an Analyst @
https://www.futuremarketinsights.com/ask-question/rep-gb-589

All the above sections, by indications, by type of organs treated and by geography evaluate the present scenario and the growth prospects of the global Gamma Knife market for the period 2021 to 2031. Given the characteristics of the market, we triangulated the outcome of three different types of analyses, based on supply side, healthcare spending and economic envelope. In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the global Gamma Knife market.

Furthermore, to understand key growth segments in terms of growth & adoption of global Gamma Knife market, Future Market Insights developed the global Market Attractiveness Index on the bases of indications, by type of organs treated and geography. The resulting index should help providers identify real market opportunities.

In the final section of the report, the global Gamma Knife competitive landscape is included to provide report audiences with a dashboard view, based on various segments, presence in global Gamma Knife market and key differentiators. This section is primarily designed to provide clients with an objective & detailed comparative assessment of key providers specific to a market segment in the global Gamma Knife value chain. Detailed profiles of the manufactures are also included in the scope of the report to evaluate their operations, expansions, products and sales channel strategies along with the SWOT analysis for each manufacture. Key competitors included are Elekta AB, Varian Medical Systems, Inc. and Huiheng Medical, Inc.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-589

Gamma Knife Market – Key Segment

By Disease Indication:

  • Brain Metastasis
  • Cancer
  • Arteriovenous Malformation (AVM)
  • Trigeminal Neuralgia
  • Others

By Anatomy:

  • Head
  • Neck
  • Other Body Parts

By Geography:

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East and Africa

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/gamma-knife-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Proteinase K Market 2022 Growth Opportunities, Top Players, Regions, Application, and Forecast to 2032

Proteinase K is a million dollar market accounting for a small portion in reagents and enzymes. Proteinase K is mainly used in contract research organisations, biotechnology companies, academic institutes, and diagnostics laboratories. In terms of revenue, the global Proteinase K market is expected to reach US$ 33.4 Mn by the end of 2026, witnessing a CAGR of 6.1%.

A plethora of factors are expected to impact the growth of the global Proteinase K market. A significant rise in research and development activities, lesser production costs, broader application of Proteinase K and good product stability and specificity of Proteinase K will give a massive push to the revenue growth of the global Proteinase K market by the end of the forecast period. A steady rise of chronic diseases and better government backed investment channels to fund advanced research and development are expected to boost the expansion of the global Proteinase K market over the period of assessment. An increasing number of research activities, soaring expenditure on personal healthcare and increasing adoption of gene therapy has been significantly high in the U.S. market in the recent years, making North America the most lucrative regional market for Proteinase K.

To remain ahead of your competitors, request for a sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-2399

Global Proteinase K Market: Segmental Forecast

  • By form, the lyophilized powder form segment is anticipated to account for higher revenue share in the global Proteinase K as compared to the liquid form segment. Lyophilized powder from segment is expected to reach a market value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.3% over the forecast period. The growth in lyophilized powder form can be attributed to the increasing advantages of powder form over liquid form in case of storage and preservation of samples.
  • By application, purification of DNA & RNA segment will account for the highest revenue share in the global Proteinase K market as compared to other applications of Proteinase K. Purification of DNA & RNA segment is expected to reach a value of US$ 19.2 Mn by 2026, reflecting a CAGR of 6.5% over the forecast period.
  • By end user, the biotechnology companies segment is expected to project higher demand for Proteinase K as compared to other end user segments such as academic institutes and diagnostics laboratories. The strong growth in biotechnology companies can be attributed to an increasing use of Proteinase K in research and development and new drug discovery. The cost effectiveness of Proteinase K over other reagents is the key factor responsible for its increasing use in biotechnology companies. The biotechnology companies segment is expected to register the highest CAGR of 6.7% over the forecast period.

Global Proteinase K Market: Regional Market Projections

Demand for research in academics and funding facilities provided by the U.S government to support gene therapy and other activities for drug development is anticipated to boost the North America Proteinase K market. Followed by North America, Western Europe and APEJ are the most lucrative regions in the global Proteinase K market and are anticipated to grow by 5.7% and 6.1% respectively over the forecast period. Increasing demand for drug development, rising hereditary diseases due to changing lifestyles and growing disposable income are some of the factors expected to contribute to the growth of the global Proteinase K market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-2399

Global Proteinase K Market: Vendor Insights

Top companies profiled in the global Proteinase K market report include Thermo Fisher Scientific Inc., Merck KGaA, Qiagen N.V., Worthington Biochemical Corporation, Sisco Research Laboratories Pvt. Ltd, Promega Corporation, Bioline and F. Hoffmann-La Roche AG among others. Leading market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Merck KGaA acquired Sigma-Aldrich to strengthen and expand its consumable and reagent portfolio.

Market Segmentation Form

  • Lyophilized Powder Form
  • Liquid Form

Application

  • Isolation and purification of genomic DNA & RNA
  • In Situ Hybridization
  • Mitochondria isolation
  • Enzyme Removal

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/proteinase-k-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

GCC Medical Gloves Market Growth, Analysis Report, Share, Trends and Overview 2022-2031

According to a recent study by Future Market Insights (FMI), the GCC medical gloves market is reached US$ 145 Mn in 2022. With sales growing at a healthy 7.9% CAGR, the market valuation is set to reach US$ 340.3 Mn by 2031. Modernization of lifestyles in GCC countries has resulted into a rise in elective surgeries which are not crucial for an individual to survive but have more of an optional nature. Elective surgeries like plastic surgery, liposuction, rhinoplasty, breast augmentation, breast reduction, blepharoplasty, etc. have been getting increasingly popular in countries like Dubai and other Gulf countries. These surgeries ultimately require a supply of necessary medical supplies including medical gloves, thereby increasing their demand.

Data Points Market Insights
GCC Medical Gloves Market Value 2021 USD 159.5 Mn
GCC Medical Gloves Market Value 2031 USD 340.3 Mn
CAGR 2021-2031 7.9%

Request a sample of thisreport @
https://www.futuremarketinsights.com/reports/sample/rep-gc-1943 

When performing any type of surgeries, chances of glove punctures while using single set of gloves are high. Therefore, professionals use double set of gloves to avoid the possibility of contamination of sterile surgical equipment. These “double gloving” practices are expected to continue boosting sales over the assessment period.

Key Takeaways:

  • By raw material, the latex material segment is expected to hold 80.2% of the total market share in 2021, expanding at 7.9% CAGR during the forecast period.
  • Based on product type, the examination gloves segment is projected to command 55.6% of total sales in 2021, expanding at 8.1% CAGR.
  • By form, the powdered form segment is expected to hold 63.7% of the total market share in 2021, expanding at 8.0% CAGR.
  • By type of use, sales of disposable gloves are anticipated to hold 90.5% of the total market share 2021, and are to projected to increase at a robust 8.0% CAGR over the forecast period.
  • By end use, hospitals will account for 67.2% of total sales in 2021.
  • By distribution channel, the direct selling channel will account for 55.1% of the total market share in 2021.
  • Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 76.2% of the GCC medical gloves market in 2021.

Request TOC @
https://www.futuremarketinsights.com/toc/rep-gc-1943 
Who is winning?

Leading players operating in the market are investing in mergers, acquisitions and collaborations with existing players and healthcare institutes to gain a competitive edge. For instance:

In August 2020, Ansell Healthcare Products LLC collaborated with Nordic company ONeMEd with an aim to expand their customer base in the Nordic countries. Ansell is one of the global leaders in hand protection equipment.

The key market players covered by FMI include Paul Hartmann AG,Hotpack Packaging Industries LLC,Falcon (Falcon Pack),Deeko Bahrain,Salalah Medical Supplies Mfg. Co. LLC,United Medical Industries,NAFA Enterprises Ltd.,Liberty Industries, Inc.,Ansell Healthcare,Mckesson Corporation,Cardinal Health, Inc.,Medline Indsutries, Inc.,Dynarex Corporation,Top Glove Corporation Berhad,Kimberly-Clark Corporation,Semperit AG Holding

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/gcc-medical-gloves-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Hypercalcemia Treatment Market Insights, Deep Analysis of Key Vendor in the Industry 2022-2032

This report by Future Market Insights (FMI) examines the Hypercalcemia Treatment Market for the period 2016-2026. The primary objective of the report is to offer updates and information related to market opportunities in the global hypercalcemia treatment market.

Data Points Market Insights
Market Value 2021 US$ 14.6 Bn
Market Value 2022 US$ 16.2 Bn
Market Value 2032 US$ 48.9 Bn
CAGR 2022-2032 11.7%
Market Share of Top 6 Countries 65.3%
Key Market Players Amgen Inc, Pfizer Inc., Mylan N. V., Sunovion, Procter And Gamble, Apotex Corporation, Genentech, Inc., Novartis AG, Bayer AG, Hoffmann La Roche, Atnahs Pharma, Cipla Inc., Sun Pharmaceuticals Industries Ltd, Dr. Reddy’s Laboratories and Aurobindo Pharma Limited..

The global hypercalcemia treatment market report begins by defining hypercalcemia treatment and various types of products used in hypercalcemia treatment. It is followed by an overview of market dynamics of the global hypercalcemia treatment market, which includes FMI’s analysis of key trends, drivers, restraints and opportunities that are influencing growth of the global hypercalcemia treatment market. Impact analysis of key growth drivers and restraints based on a weighted average model have been included in the global hypercalcemia treatment market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market.

Primary factors fuelling demand for hypercalcemia treatment include increasing prevalence of hyperparathyroidism-related hypercalcemia, increasing number of patients with cancers, higher incidence of multiple myeloma, availability of appropriate drug therapy alternative over surgery, favourable reimbursement scenario and drug therapies to avoid kidney failure. However, primary factors hampering growth of the hypercalcemia treatment market are patient location, hypercalcemia drug adoption and cost recovery from limited patient population.

Request Sample PDF Brochure@
https://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market

Based on product type, the market has been segmented bisphosphonates (clodronate, etidronate, ibandronate, pamidronate and zoledronic acid), calcitonin, glucocorticoids, denosumab and calcimimetics. A detailed analysis has been provided for these segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

Based on distribution channel, the market has been segmented into hospitals, clinics and independent pharmacy and drug stores. Our analysis predicts that revenue form the independent pharmacy and drug stores segment will expand at a relatively fast pace, and the segment is expected to contribute significantly towards the distribution of hypercalcemia drugs during the forecast period. Hospitals distribution channel segment is projected to generate comparatively high revenue owing to novel and easy availability of hypercalcemia treatment drugs worldwide.

The next section of the report highlights hypercalcemia treatment market by region and provides market outlook for 2016–2026. The report also discusses key regional trends contributing to revenue growth of the global hypercalcemia treatment market, as well as analyses the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

The above sections – by product type, distribution channel and region — evaluate the present scenario and growth prospects of the hypercalcemia treatment market for 2016–2026. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016–2026.

To ascertain hypercalcemia treatment market size, we have also considered revenue generated by companies operating in the hypercalcemia treatment market space. The forecast presented here assesses the total revenue by value across the hypercalcemia treatment market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the hypercalcemia treatment market is expected to develop in future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecast in terms of CAGR, but also analyse on the basis of key parameters such as Year-on-Year (Y-o-Y) growth rates. This is imperative to understand the predictability of the market and to identify the right opportunities across the global hypercalcemia treatment market.

Ask for Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-1320

The hypercalcemia treatment market has been segmented on the basis of product type, distribution channel and region. These segments are analysed in terms of Basis Point Share (BPS) to understand each individual segment’s relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global hypercalcemia treatment market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is normally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

To understand key segments in terms of growth and adoption for hypercalcemia treatment drugs globally, FMI has developed the hypercalcemia treatment market ‘Attractiveness Index’. The resulting index is expected to help providers identify real market opportunities in the global hypercalcemia treatment market.

In the final section of the report on the global hypercalcemia treatment market, ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of drug developers in the hypercalcemia treatment market space and key differentiators. Key categories of providers covered in the report are companies developing hypercalcemia treatment drugs. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the hypercalcemia treatment value chain and the potential players for the same. Report audiences can gain segment-specific company insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in hypercalcemia treatment marketplace.

Detailed profiles of the hypercalcemia treatment developing companies are also included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis and recent developments in the global hypercalcemia treatment market.

Key companies covered in report are Bayer Pharma AG, Sun Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Amgen Inc., Novartis AG, Dr. Reddy’s Laboratories Ltd. and Cipla Inc.

Inquire Before Buying Research Report@
https://www.futuremarketinsights.com/ask-question/rep-gb-1320

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/hypercalcemia-treatment-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Balloon Catheter Market Witness a Spike in Growth Pace Recent Improvements in Pricing Models: FMI

According to a recent study by Future Market Insights (FMI), the global balloon catheter market is expected to witness high growth during the forecast period. Sales are expected to reach US$ 5.11 Bn by the end of 2031. This reflects a cumulative CAGR of around 4.0% over the forecast period (2021-2031).

Market Value 2020 US$ 3.33 Bn
Market Value 2021 US$ 3.55 Bn
Market Value 2031 US$ 5.11 Bn
CAGR 2021-2031 4.0%
Share of Top 5 Countries 57.3%

Drug eluting balloons are playing an important role by facilitating the push mechanism, through the drug treatment. Excipient coated balloons offer a high efficacy and viability for the transfer of the drug.

Development in such technologies is increasing the use of balloon catheters, boosting the market. Hence, to gain competitive edge, key players are developing advanced drug eluting balloon.

Subsequently, these companies are getting approvals from the governments to commercially manufacture these balloons. This is expected to bode well for the growth in the market.

Furthermore, due to prolonged stay at the hospital in angioplasty procedures, preference for the same is decreasing among patients with coronary artery disease (CAD). Hence, with attributes such as minimal invasion of drug eluting balloon catheters, demand is increasing among CAD patients.

Request a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1916

Hence, efforts are being taken by public authorities, NGO’s, and government to spread awareness regarding the positive benefits of balloon catheters. For instance, campaigns such as “Spread the Word Campaign”, educating women on CAD and its treatments solutions by Healthy Women and National Association for Nurse Practitioners.

A slew of such activities are expected to increase the demand for balloon catheters over the forecast period.

Key Takeaways

  • By product, normal balloon catheter holds the maximum share of 43.9% in 2021, expanding at 0.8% CAGR during the forecast period.
  • By indication, coronary artery disease is anticipated to account for nearly 71.5% market share in terms of value due to the high prevalence of coronary artery diseases across the globe
  • By raw material, the nylon segment holds 46.3% of the market share, registering 4.0% CAGR  in 2021
  • Polyurethane catheters are expected to hold second-largest share, contributing 34% of overall sales in 2021.
  • By end user, the hospital segment will account for 70.5% of the market share in 2021 due to the availability of advanced technology and need for minimally invasive surgical procedures.
  • By region, North America held the largest share of 31.7% in the global Balloon Catheter market in 2021.

Ask an Analyst@
https://www.futuremarketinsights.com/ask-question/rep-gb-1916

Who is winning?

Some of the leading manufacturers of balloon catheters market are focusing on product launches for expansion of their product portfolio. They are also aiming for strategic mergers and partnerships, thereby, strengthening their global presence.

  • In January 2021, Shanghai MicroPort Medical (Group) Co., Ltd. received official license from the Taiwan Ministry of Health and Welfare (MOHW) for its proprietary coronary balloon dilatation catheter, Firefighter™ NC. This new technology will help in dilatation of the stenosed coronary tracts and improve myocardial perfusion.
  • MicroPort Scientific Corporation, on 8 June 2021, introduced trademark Cardiac Cryoablation System known as IceMagic consisting of cryoablation device, cryoballoon catheters, a disposable cardiac mapping catheter. The company with innovative use of cryogenic technology aims to make their entrance into the foreign market outside of China in the treatment of atrial fibrillation.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2031. The global balloon catheters market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into balloon catheters. The balloon catheters market is segmented on the basis of product (normal balloon catheter, cutting balloon catheter, scoring balloon catheter, drug eluting balloon catheter, stent graft balloon catheter), raw material (polyurethane, nylon, others), indication (coronary artery disease, peripheral vascular disease), and end user (hospitals(private hospitals, public hospitals), ambulatory surgical centers, cardiac catheterization laboratories) across seven major regions.

Ask For Customization@
https://www.futuremarketinsights.com/customization-available/rep-gb-1916

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/balloon-catheter-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Special Purpose Needles Market Key Players, End User, Demand and Consumption by 2032

The global special purpose needles market is projected to be valued at US$ 17,261.5 million by the end of 2026, registering a CAGR of 7.4% during the forecast period (2016–2026). In a new report titled “Special Purpose Needles Market: Global Industry Analysis and Opportunity Assessment, 2016–2026”, Future Market Insights delivers key insights on the factors and trends impacting the global special purpose needles market over a 10-year forecast period (2016–2026).

Attributes Key Insights
Global Special Purpose Needles Market Estimated Size (2022E) US$ 12.6 Bn
Projected Market Valuation (2032F) US$ 27.0 Bn
Value-based CAGR (2022-2032) 7.9%
Collective Value Share: Top 5 Countries 54.8%

The market for special purpose needles is witnessing steady growth across the globe owing to an increasing geriatric population. According to analysts at Future Market Insights, “Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market.” Availability of better reimbursement options for some types of special purpose needles in developed economies is likely to propel demand for special purpose needles over the forecast period. A key trend witnessed in the global special purpose needles market is the development of advanced techniques in the production of special purpose needles to facilitate enhanced patient safety and comfort. However, rise in awareness on needle free injections and risks associated with injections are major factors expected to hamper the overall growth of the special purpose needles market over the forecast period.

To remain ahead of your competitors, request for a sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-583

The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies, Private Clinics,   Retail Pharmacies and Drug Stores, E-Commerce).

Segmentation highlights

  • The Pen Needles product type segment is expected to gain popularity over the forecast period, driven by increasing global adoption of small sized needles for insulin injections. The Pen Needles product type segment is estimated to reach a valuation of US$ 644.3 Mn by the end of 2016, registering a CAGR of 9.1% over the forecast period.
  • The Sample Collection application segment is estimated to register a CAGR of 7.7% while the Drug Delivery application segment is expected to register a CAGR of 7.1% during the forecast period.
  • Demand for special purpose needles over the forecast period is expected to be the highest in the Hospital Pharmacies distribution channel segment, which is expected to register a CAGR of 8.5% in terms of value.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-583

Regional forecast

The North America market has been estimated to dominate the special purpose needles market while the market in APEJ is expected to be the fastest growing in terms of revenue growth. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.

Vendor insights

Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major companies operating in the global special purpose needles market. These companies are adopting innovative strategies to bring in improvements to their product design and are initiating advanced R&D activities and market consolidation to strengthen market foothold and expand customer base.

For in-depth insights, Download a PDF Brochure@
https://www.futuremarketinsights.com/reports/brochure/rep-gb-583

Market segmentation By Product Type

  • Fine Aspirating Needles
  • Biopsy Needles
  • Hypodermic Needles
  • Pen Needles
  • Suture Needles
  • IV Catheter Needles
  • Implantation Needles
  • Dental Needles
  • Ophthalmic Needles
  • Blood Collection Needles
  • Spinal Anaesthesia Needles
  • Epidural Needles
  • AV Fistula Needles
  • Cannula Needles

By Application

  • Sample Collection
  • Drug Delivery

By Distribution Channel

  • Hospital Pharmacies
  • Private Clinics
  • Retail Pharmacies and Drug Stores
  • E-Commerce

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/special-purpose-needles-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

GCC Syringes and Needles Market Impacted by COVID-19, Market to Remain Dormant in Near Term, Projects FMI 2022 -2031

According to a recent study by Future Market Insights (FMI), the GCC syringes and needles market is expected to register high growth during the forecast period. The market is expected to grow from US$ 525.4 Mn in 2020 to over US$ 1.33 Bn by 2031. This reflects a CAGR of around 8.8% over the forecast period (2021-2031).

Data Points Market Insights
GCC Syringes and Needles Market Value 2020 US$ 525.4 Mn
GCC Syringes and Needles Market Value 2021 US$ 573.0 Mn
CAGR 2021-2031 8.8%
Key Players The key players of this industry are Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Medtronic PLC, Smiths Group PLC, Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC., and IBN Sina Medical Factory.

GCC countries have been prioritizing their healthcare sector owing to the increasing population along with a growing burden of geriatric population. There has been a significant increase in the prevalence of lifestyle disorders and other chronic non-communicable diseases in these countries.

This has resulted in the high demand syringes and needles as systems for accurate drug delivery for the treatment of various chronic ailments.

Government reforms and initiatives have been introduced to improve their healthcare systems and various changes have been made to improve the efficiency and quality of healthcare system in the countries. Favorable policies aimed at expansion of healthcare sector will present conducive environment for the growth of the market.

According to an article published in the Saudi Medical Journal, the prevalence of diabetes was around 31.6% in the Kingdom of Saudi Arabia in the year 2017. Furthermore, increasing prevalence of other chronic diseases such as cardiovascular diseases, cancer, and other non-communicable diseases along with diabetes, which require long term care, contribute majorly in the increasing demand for disposable syringes and needles in these countries and will positively impact the market growth over the forecast period.

Request a sample @
https://www.futuremarketinsights.com/reports/sample/rep-gc-1874

In February 2021, the Chairman of Department of Health, His Excellency Mohammed Al Hamed visited the Abu Dhabi Medical Devices company’s headquarters factory to oversee the efforts been taken to contribute to the COVID-19 pandemic since the company has made collaborations with various international organizations like UNICEF and COVAX to supply syringes and needles for the vaccination program worldwide.

Such developments not only strengthens the company’s existing portfolio but also help to increase their presence at the regional as well as global level, and helps companies to sustain the increasing competitive pressure. These developments are expected to favor growth of the GCC syringes and needles market.

Key Takeaways from GCC Syringes and Needles Study

  • Hypodermic syringes and needles will remain the top-selling product in the market, accounting 87.6% of demand in 2021.
  • By usability, the disposable syringes and needles will account for dominant share of 81.3% in the market in 2021.
  • By material, the polymer syringes and needles are expected to register high demand. Sales in this category will grow by 8.9% during the forecast period.
  • By end user, the hospital segment will account for 66.9% of the market share in 2021.
  • By countries, Kingdom of Saudi Arabia (KSA) is anticipated to hold the largest share of 73.6% of the GCC syringes and needles market in 2021.

Who is winning?

Some of the leading manufacturers of syringes and needles market are focusing on product launch, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

Request a TOC@
https://www.futuremarketinsights.com/toc/rep-gc-1874

  • In June 2021, Becton, Dickinson and Company announced that they have received a huge order of 2 billion injection devices which would be used for the vaccination programs around the globe.
  • In April 2019, B. Braun Medical Inc., announced the launch of their first FDA approved Heparin Sodium prefilled syringe injection which has attached safety needle for subcutaneous and intravenous use.

The key market players covered by FMI include Becton, Dickinson and Company, Nipro Corporation, Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Medtronic PLC, Smiths Group PLC,  Abu Dhabi Medical Devices Company, SAAPP (FZC) LLC. and IBN Sina Medical Factory

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The GCC syringes and needles market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into syringes and needles market. The syringes and needles market is segmented into two parts based on product (oral and hypodermic) based on usability (disposable and reusable) based on material (glass and polymer) based on end user (hospitals, blood collection centers, diabetic care centers, veterinary care centers, and others)and based on country ( KSA, UAE, Qatar, Bahrain, Oman and Kuwait).

Ask An expert here @
https://www.futuremarketinsights.com/askus/rep-gc-1874

GCC Syringes and Needles by Category

Product:

  • Oral
  • Hypodermic
    • Standard
    • Special Purpose
      • Insulin
      • Tuberculin
      • Other Special Purpose
      • Angiographic

Usability:

  • Disposable
  • Reusable

Material:

  • Glass
  • Polymer

End User:

  • Hospital
  • Blood Collection Center
  • Diabetic Care Center
  • Veterinary Care Center
  • Others

Countries:

  • Kingdom of Saudi Arabia (KSA)
  • United Arab Emirates (UAE)
  • Qatar
  • Bahrain
  • Oman
  • Kuwait

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/gcc-syringes-and-needles-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Traditional Wound Management Market Remains Afloat amid COVID-19 Pandemic, to Surge Positively, Projects FMI 2022-2032

The global traditional wound management market is anticipated to create lucrative opportunities over the assessment period ranging from 2022 to 2032, by enjoying a valuation of US$ 5.1 Bn by the end of the year 2022 and exceedingly around US$ 6.9 Bn by the year 2032.

Attributes Key Insights
Traditional Wound Management Market Value 2021 US$ 4.9 Bn
Estimated Market Size 2022 US$ 5.1 Bn
Projected Market Value 2032 US$ 6.9 Bn
CAGR 2022-2032 3.2%
Market Share of Top 5 Countries 51.7%

As per the recent study by Future Market Insights, the gauze segment by product is leading the market with a share of about 39.7% in the year 2021, within the global market. The global wound care market is predicted to be valued at US$ 18.4 Bn out of which traditional wound management consists of a share of 26.6%, in 2021.

During the traditional period from 2014 to 2021, the market for traditional wound management expanded at a CAGR of 2.9%. Traditional wound management is expected to experience a shift in dynamics owing to the changes in demographics of the geriatric population and the growing incidence of wounds, owing to the rising problem of infection acquired during surgical procedures globally.

Furthermore, the surgical list falls under the care of chronic wounds. The surge of trauma and chronic diseases such as diabetes and ulcers are the leading cause of the rising demand for the traditional wound management market.

Get a Sample Copy of the Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-857

Key Takeaways

  • The market is expected to showcase an optimistic outlook, owing to the cost-effectiveness and clear reimbursement policies. The drastic inclination towards wound healing and care dynamics along with the adoption of traditional wound management products presents a significant revenue opportunity for the traditional wound management sector.
  • The surging number of chronic wound patients has encouraged the development and implementation of therapies that help in the promotion of faster and more efficient wound healing. Early healing is predicted to assist the lower and average length of hospital stays. A chronic wound is a chronic health problem because it frequently spreads to the surrounding tissues, resulting in infection and amputation.
  • Several infections were caused owing to the rise of serious health issues and therefore resulted in the addition of overall system costs. Therefore, traditional methods of wound care and cleansing are re-evaluated and as a result, traditional wound care products are incorporated into the patient and wound care system for the reduction of infection-related costs.
  • Irrespective of the availability of advanced wound care and healing products, major healthcare professionals and facilities choose traditional wound management products due to their cost-effectiveness and long-term training and research experience.
  • The surge in various surgical procedures, the aging population, and the surge in the adoption of technically advanced products, are some of the factors driving the market. The hurdles faced are due to a lack of skilled professionals, general awareness about wound care, and rising medical waste.

Competitive Landscape

With numerous competitors in the traditional wound management market landscape, the overall industry is fragmented. In order to meet consumer demand and expand their customer base, these companies are implementing methods such as expanding their production capabilities by constructing new factories and manufacturing facilities also indulging in partnerships and collaborations and availing new product launches with technological advancements.

Before Buying, Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-857

Key Companies Profiled

  • Smith & Nephew plc.
  • B. Braun Melsungen AG
  • Johnson & Johnson Pvt. Ltd.
  • Medtronic Plc.
  • Cardinal Health,
  • Derma Sciences Inc.
  • Paul Hartman AG
  • Molnlycke Health Care
  • Medline Industries, Inc.
  • DUKAL Corporation
  • BSN Medical

Key Market Segments Covered in Traditional Wound Management Industry Research

By Product:

  • Bandages
    • Adhesive Bandages
    • Non-adhesive Bandages
    • Compression Bandages
  • Gauzes
    • Woven Gauzes
    • Non-woven Gauzes
  • Gauze Sponge
    • Woven Gauze Sponges
    • Non-woven Gauze Sponges
  • Sponges
    • Woven Sponges
    • Non-woven Sponges

By Application:

  • Skin and Diabetic Ulcers
  • Burns
  • Surgeries
  • Trauma
  • Others (skin cuts, primary dressings, etc.)

By End User:

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Homecare Settings
  • Ambulatory Surgical Centers

Request Advisory customization available@
https://www.futuremarketinsights.com/customization-available/rep-gb-857

More Insights into the Traditional Wound Management Market

The U.S. is expected to dominate the global traditional wound management market as it accounted for around 26.4% in 2021 and is expected to continue to experience the same growth throughout the forecast period.

China is the second largest manufacturer of traditional wound management. According to the estimations, China is expected to account for 6.0% of globally. The market is expected to surge at a robust pace over the forecast period due to rising healthcare facilities in the region along with the presence of prominent manufacturers.

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/traditional-wound-management-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs 

Excimer and Femtosecond Ophthalmic Lasers Market Forecast with Potential Impact, Despite COVID-19 Pandemic, Finds FMI 2022 – 2032

The global excimer and femtosecond ophthalmic lasers market is projected to rise at a robust pace of 8.0% CAGR over the assessment years from 2022 to 2032. The global market reached US$ 1.02 Bn in 2021 and is expected to touch a valuation of US$ 1.18 Bn by the end of 2022. The global market is anticipated to exceed a valuation of US$ 2.41 Bn by 2032.

Attribute Key Statistics
Excimer and Femtosecond Ophthalmic Lasers Market Base Value (2021) US$ 1.02 Bn
Estimated Market Value (2022) US$ 1.18 Bn
Projected Market Value (2032) US$ 2.41 Bn
Value-based CAGR of (2022-2032) 8.0%
Market share of Top 5 countries 56.5%

The growth in the global excimer and femtosecond ophthalmic lasers market is attributed to the increasing prevalence of eye diseases across the world and the surging adoption of ophthalmic lasers, the overall sales of excimer and femtosecond ophthalmic lasers are projected to rise.

An excimer laser is known as a form of ultraviolet laser which is commonly utilized in ophthalmic surgeries. Excimer laser photorefractive keratectomy and excimer laser in-situ keratomileusis (LASIK) are some of the most common procedures conducted using a laser which is used to rectify refractive errors of the eye, as excimer laser alters the refractive state of the eye by removing tissue from the anterior cornea.

On the basis of application, the refractive surgeries segment dominated the global Excimer and Femtosecond Ophthalmic Lasers Market with a total value share of nearly 69% in 2021.

Get a Sample Copy of the Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1717

The excimer and femtosecond ophthalmic lasers are prominently used in surgical care for treating numerous eye disorders on account of their safe, precise, and accurate nature. Attributing to such attractive benefits and technological advancements, excimer and femtosecond ophthalmic lasers have the potential to become the gold standard of eye surgeries.

The increasing prevalence of multiple eye disorders such as glaucoma, macular degeneration, and diabetic retinopathy along with a surge in the number of eye surgeries performed worldwide is expected to bolster the growth of the Excimer and Femtosecond Ophthalmic Lasers Market during the assessment period.

Key Takeaways

  • An increase in the opening of ophthalmology clinics and hospitals in many nations all over the world is expected to propel growth in the market. Due to the rise in the number of elderly people visiting ophthalmology clinics and hospitals as well as the large numbers of diabetic people who have eye disease or are at risk of developing it. These aforementioned factors are anticipated to grow femtosecond and excimer ophthalmic laser market growth during the next ten years.
  • The government and several other regulatory bodies are meticulously working in order to make eye care services a crucial part of universal health coverage and address the increasing impact of vision loss on sustainable development. This is expected to create lucrative growth prospects within the global excimer and femtosecond laser market.
  • In order to provide ophthalmologists with some of the best equipment possible to efficiently perform delicate eye procedures, ophthalmic laser manufacturers are constantly improving their laser systems.
  • In comparison to manual surgery, Femtosecond laser cutting is done with greater precision and accuracy. Growth in the global excimer & femtosecond ophthalmic lasers market is mainly driven by the increasing diabetic and aging population globally. This increase is resulting in a rise in the number of common ophthalmic disorders such as cataracts, glaucoma, etc.
  • The surge in the prevalence of age-related macular degeneration (AMD), glaucoma, cataract, diabetic retinopathy, and presbyopia require surgical correction to restore normal vision. Therefore, the increased aging and diabetic population is a major factor expected to fuel the growth of the global Excimer and Femtosecond Ophthalmic Lasers Market over the forecast period.

Competitive Landscape

The prominent market players in the healthcare sector are utilizing FLACS, or femtosecond laser-aided cataract surgery, as a safe and efficient therapy option for elderly patients, which is rapidly gaining ground. Hand-held surgical instruments in several procedures such as cataract fragmentation, anterior capsulotomy, and corneal incision are being drastically replaced by more efficient lasers resulting in increased accuracy and precision.

Key Companies Profiled: –

Medtronic Public Limited Company, Boston Scientific Corp, St Jude Medical LLC and Nevro Corp, Nuvectra Corporation and Stimwave, Neurosigma Inc., Synapse Biomedical Inc., Abbott Laboratories, Beijing PINS Medical Co., Ltd, Cirtec Medical Corporation, Gimer Medical, Bluewind Medical, Bioinduction, Greatbatch, Inc., Saluda Medical Pty Ltd.

Before Buying, Visit for Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-1717

Excimer and Femtosecond Ophthalmic Lasers Market Segments

Product:

  • Excimer Laser
  • Femtosecond Laser

Application:

  • Refractive Surgery
  • Cataract Surgery
  • Capsulotomy
  • Trabeculoplasty
  • Diagnosis

End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Ophthalmology Clinics

More Insights into the Excimer and Femtosecond Ophthalmic Lasers Market

The U.S. is expected to dominate the global excimer and femtosecond ophthalmic lasers market as it accounted for more around 81.8% of the North American Excimer and Femtosecond Ophthalmic Lasers Market in 2021 and it is poised to grow at a robust pace during the next ten years.

Read Related Reports:

https://degentevakana.com/blogs/view/121254
https://vocal.media/stories/hypoparathyroidism-treatment-market-2022-scope-of-current-and-future-industry-2031
https://www.dronepilotlari.com/blogs/52528/Saudi-Arabia-Pharmaceutical-Market-2022-Key-Players-SWOT-Analysis-Key
https://vocal.media/stories/frontotemporal-disorders-treatment-market-2022-scope-of-current-and-future-industry-2028

About FMI                     

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:                                        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
Report: https://www.futuremarketinsights.com/reports/excimer-femtosecond-ophthalmic-lasers-market
For Sales Enquiries: sales@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs